🔎 Trials Near Me

Utama › Neuroblastoma › Pennsylvania › Philadelphia

Kajian klinikal Neuroblastoma di Philadelphia, PA

9 kajian untuk Neuroblastoma sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Mengambil pesertaFasa 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Saint Christopher's Hospital for Children, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi jauh
Sehingga umur 30 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Mengambil pesertaFasa 3
  • Children's Hospital of Philadelphia, Philadelphia
  • Alfred I duPont Hospital for Children, Wilmington · 25 mi jauh
365 Days – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Mengambil pesertaFasa 1/2
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 30 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

Mengambil pesertaFasa 1/2
  • Children's Hospital of Philedephia, Philadelphia
Umur 2 hingga 21 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05642455

PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors

Mengambil pesertaFasa 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Umur 1 hingga 30 · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06721689

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

Mengambil pesertaFasa 2
  • Children's Hospital of Philadelphia, Philadelphia
Umur 1 hingga 31 · Semua jantina · Dikemas kini 20 Jul 2026 · NCT06450041

Neuroblastoma Biology Study

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Philadelphia, Philadelphia
31 Days – 99 Years · Semua jantina · Dikemas kini 23 Mac 2026 · NCT01587300

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Mengambil peserta
  • Children's Hospital of Philadelphia, Philadelphia
Sehingga umur 17 · Semua jantina · Dikemas kini 10 Feb 2026 · NCT06831552

Kajian Neuroblastoma di bandar lain

Kajian lain di Philadelphia

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.